Recent progress in cancer treatment continue to present optimism for patients. Researchers are intensely exploring cutting-edge approaches, including immunotherapy , targeted therapies , and personalized medicine . A key research published this week showcases the effectiveness of a new drug in managing late-stage NSCLC. Furthermore, continued inves